ANIKAnika Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of Anika Therapeutics, Inc. against SIC 3841 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ANIK본 종목 | $279M#6 | — | 2.0x#3 | 2.5x#5 | -5.9%#9 | 80.4%#3 | -9.8%#6 | -8.0%#4 | -8.8%#4 | 4#6 | 141.0%#2 | — |
| OBIO | $362M#1 | — | 3.6x#4 | 10.8x#11 | 1169.2%#1 | 13.6%#7 | -154.7%#11 | -52.8%#7 | -54.9%#8 | — | 151.1%#1 | 5.5%#2 |
| CTSO | $360M#2 | — | — | 9.7x#10 | 4.1%#5 | 60.4%#4 | -39.8%#8 | — | -122.1%#9 | 4#6 | — | — |
| TLSI | $303M#3 | — | 46.3x#9 | 6.7x#9 | 53.4%#2 | -30.6%#10 | -59.7%#9 | -598.9%#9 | — | 5#4 | — | — |
| TMCI | $296M#4 | — | 4.4x#6 | 1.4x#2 | 1.6%#6 | -5.8%#8 | -25.5%#7 | -87.1%#8 | -47.4%#7 | 2#8 | -35.5%#3 | — |
| EMBC | $291M#5 | 3.5x#1 | — | 0.3x#1 | -3.8%#7 | 21.8%#6 | 22.4%#2 | — | 27.0%#1 | 6#2 | -61.8%#4 | 12.0%#1 |
| INFU | $248M#7 | 31.2x#4 | 4.2x#5 | 1.7x#3 | 6.4%#4 | 182.6%#2 | 8.3%#4 | 11.2%#2 | 9.5%#3 | 9#1 | — | — |
| OSUR | $241M#8 | — | 0.8x#1 | 2.1x#4 | -38.1%#11 | -252.5%#11 | -62.6%#10 | -21.6%#6 | -43.8%#6 | — | — | — |
| IDXG | $240M#9 | 9.9x#2 | 10.3x#8 | 6.2x#8 | -17.5%#10 | 267.2%#1 | 10.5%#3 | 105.8%#1 | 14.2%#2 | 5#4 | — | — |
| UTMD | $236M#10 | 22.6x#3 | 1.9x#2 | 6.1x#7 | -5.8%#8 | -18.7%#9 | 29.6%#1 | 9.2%#3 | — | — | — | 1.7%#3 |
| KRMD | $148M#11 | — | 8.2x#7 | 3.6x#6 | 22.2%#3 | 56.5%#5 | -7.2%#5 | -14.6%#5 | -29.4%#5 | 6#2 | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 3841). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-09-16.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice